A Peptide Mimicking a Region in Proliferating Cell Nuclear Antigen Specific to Key Protein Interactions Is Cytotoxic to Breast Cancer-Reference-Cited by-同舟云学术

A Peptide Mimicking a Region in Proliferating Cell Nuclear Antigen Specific to Key Protein Interactions Is Cytotoxic to Breast Cancer

Published:2014-12-05 Issue:2 Volume:87 Page:263-276
ISSN:0026-895X
Container-title:Molecular Pharmacology
language:en
Short-container-title:Mol Pharmacol

Author:

Smith Shanna J.,Gu Long,Phipps Elizabeth A.,Dobrolecki Lacey E.,Mabrey Karla S.,Gulley Pattie,Dillehay Kelsey L.,Dong Zhongyun,Fields Gregg B.,Chen Yun-Ru,Ann David,Hickey Robert J.,Malkas Linda H.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference59 articles.

1. Systemic therapy options in BRCA mutation-associated breast cancer

2. A unique form of proliferating cell nuclear antigen is present in malignant breast cells;Bechtel;Cancer Res,1998

3. Structural analysis of a eukaryotic sliding DNA clamp–clamp loader complex

4. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro;Brinkley;Cancer Res,1980

5. Structural and Thermodynamic Analysis of Human PCNA with Peptides Derived from DNA Polymerase-δ p66 Subunit and Flap Endonuclease-1

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the therapeutic potential of thymol from Nigella sativa L. seed: selective anticancer action against human breast cancer cells (MCF-7) through down-regulation of Cyclin D1 and proliferative cell nuclear antigen (PCNA) expressions;Molecular Biology Reports;2024-01-03

2. Targeting proliferating cell nuclear antigen (PCNA) for cancer therapy;Advances in Pharmacology;2024

3. The potential of PCNA inhibition as a therapeutic strategy in cervical cancer;Journal of Medical Virology;2023-11

4. Small molecule targeting of transcription-replication conflict for selective chemotherapy;Cell Chemical Biology;2023-10

5. Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer;Frontiers in Immunology;2023-08-25